Our preliminary studies also have identified other candidate targets of NME1 histidine kinase activity, including ENO1, GAPDH, and PKM, all proteins with potential roles in glycolysis, suggesting that the associations of NME1 expression with neuroblastoma patient outcomes may also be linked to effects on cellular metabolism. The gene discussed is NME1; the disease is neuroblastoma.